TRZ-2 is a synthetic 39-amino acid peptide designed as a dual Glucose-Dependent Insulinotropic Polypeptide (GIP)and Glucagon-Like Peptide-1 (GLP-1) receptor agonist. This compound is engineered for high-affinity binding to both receptors, allowing researchers to study the synergistic effects of "twincretin" signaling on metabolic regulation.

Mechanism of Action & Research Focus

TRZ-2 serves as a critical tool for investigating the complex interplay between incretin mimetics and metabolic homeostasis. Research involving TRZ-2 typically focuses on:

• Dual Receptor Synergism: Examining how simultaneous GIP and GLP-1 receptor activation influences glucose-dependent insulin secretion.

• Gastric Emptying Kinetics: Studying the rate of nutrient absorption and its subsequent effect on postprandial glucose fluctuations.

• Lipid Metabolism: Investigating the compound's impact on adipocyte sensitivity and fatty acid oxidation.

• Hypothalamic Signaling: Researching the modulation of satiety signals within the central nervous system to understand appetite regulation pathways.

Technical Specifications

• Amino Acid Sequence: 39-Amino Acid synthetic peptide.

• Molecular Class: Incretin Mimetic / Dual Agonist.

• Format: Lyophilized (Freeze-dried) white powder.

• Reconstitution: Requires Bacteriostatic Water for laboratory use.

Laboratory Storage & Handling

For optimal peptide stability, TRZ-2 should be stored at -20°C upon arrival. Once reconstituted with a bacteriostatic diluent, the solution should be refrigerated at 2°C to 8°C and utilized within a controlled experimental timeline to prevent degradation.

Research Use Disclaimer

WARNING: TRZ-2 is a potent research chemical intended strictly for in vitro and laboratory research use only. It is not a food, drug, or cosmetic. This product has not been approved for human or animal consumption. Any use outside of a controlled laboratory setting is strictly prohibited.